155 related articles for article (PubMed ID: 23168913)
1. Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders.
Farahani M; Bokharaei-Salim F; Ghane M; Basi A; Meysami P; Keyvani H
J Med Virol; 2013 Feb; 85(2):235-40. PubMed ID: 23168913
[TBL] [Abstract][Full Text] [Related]
2. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease.
Bokharaei-Salim F; Keyvani H; Monavari SH; Alavian SM; Madjd Z; Toosi MN; Mohammad Alizadeh AH
J Med Virol; 2011 Jun; 83(6):989-95. PubMed ID: 21503911
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
Bastani MN; Bokharaei-Salim F; Keyvani H; Esghaei M; Monavari SH; Ebrahimi M; Garshasebi S; Fakhim S
Arch Virol; 2016 Jul; 161(7):1899-906. PubMed ID: 27132015
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
Bokharaei-Salim F; Keyvani H; Esghaei M; Zare-Karizi S; Dermenaki-Farahani SS; Hesami-Zadeh K; Fakhim S
J Med Virol; 2016 Nov; 88(11):1960-6. PubMed ID: 27463051
[TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
[TBL] [Abstract][Full Text] [Related]
6. Presence of different hepatitis C virus genotypes in plasma and peripheral blood mononuclear cell samples of Iranian patients with HIV infection.
Dehghani-Dehej F; Sarvari J; Esghaei M; Hosseini SY; Garshasbi S; Kalantari S; Monavari SH; Fakhim A; Keyvani H; Bokharaei-Salim F
J Med Virol; 2018 Aug; 90(8):1343-1351. PubMed ID: 28845894
[TBL] [Abstract][Full Text] [Related]
7. Seronegative hepatitis C virus infection in patients with lymphoproliferative disorders.
Kisiel E; Radkowski M; Pawelczyk A; Horban A; Stanczak J; Bukowska-Ośko I; Caraballo Cortes K; Kaźmierczak J; Popiel M; Laskus T
J Viral Hepat; 2014 Jun; 21(6):424-9. PubMed ID: 24138606
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of occult hepatitis C without the need for a liver biopsy.
Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V
J Med Virol; 2010 Sep; 82(9):1554-9. PubMed ID: 20648609
[TBL] [Abstract][Full Text] [Related]
9. Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta-thalassemia major: Occult HCV infection.
Kahyesh-Esfandiary R; Sadigh ZA; Esghaei M; Bastani MN; Donyavi T; Najafi A; Fakhim A; Bokharaei-Salim F
J Med Virol; 2019 Jan; 91(1):107-114. PubMed ID: 30091793
[TBL] [Abstract][Full Text] [Related]
10. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.
Castillo I; Rodríguez-Iñigo E; Bartolomé J; de Lucas S; Ortíz-Movilla N; López-Alcorocho JM; Pardo M; Carreño V
Gut; 2005 May; 54(5):682-5. PubMed ID: 15831916
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection.
Donyavi T; Bokharaei-Salim F; Khanaliha K; Sheikh M; Bastani MN; Moradi N; Babaei R; Habib Z; Fakhim A; Esghaei M
Arch Virol; 2019 Oct; 164(10):2493-2504. PubMed ID: 31346769
[TBL] [Abstract][Full Text] [Related]
13. Occult hepatitis C virus infection and associated predictive factors: the Pakistan experience.
Idrees M; Lal A; Malik FA; Hussain A; Rehman Iu; Akbar H; Butt S; Ali M; Ali L; Malik FA
Infect Genet Evol; 2011 Mar; 11(2):442-5. PubMed ID: 21184846
[TBL] [Abstract][Full Text] [Related]
14. Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
García-Bengoechea M; Basaras M; Barrio J; Arrese E; Montalvo II; Arenas JI; Cisterna R
Am J Gastroenterol; 1999 Jul; 94(7):1902-5. PubMed ID: 10406257
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users.
Sheikh M; Bokharaei-Salim F; Monavari SH; Ataei-Pirkooh A; Esghaei M; Moradi N; Babaei R; Fakhim A; Keyvani H
Arch Virol; 2019 Feb; 164(2):349-357. PubMed ID: 30390150
[TBL] [Abstract][Full Text] [Related]
16. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
Zaghloul H; El-Sherbiny W
Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran.
Nasimzadeh S; Azaran A; Jalilian S; Makvandi M; Seyedian SS; Keikhaei B; Mehr FJ
Arch Virol; 2021 Oct; 166(10):2703-2710. PubMed ID: 34275067
[TBL] [Abstract][Full Text] [Related]
18. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
[TBL] [Abstract][Full Text] [Related]
19. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
20. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
